Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 18, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

December 31, 2027

Conditions
Geographic AtrophyAge-Related Macular Degeneration
Interventions
DRUG

K8

sustained released bio-erodible intravitreal implants

Trial Locations (9)

24019

RECRUITING

Vistar Eye Center, Roanoke

24201

NOT_YET_RECRUITING

Southeastern Retina Associates, Bristol

37343

NOT_YET_RECRUITING

Southeastern Retina Associates, Hixson

40508

RECRUITING

University of Kentucky Advanced Eye Care, Lexington

57108

RECRUITING

Ophthalmology LTD, Sioux Falls

92354

NOT_YET_RECRUITING

Loma Linda University, Loma Linda

97401

RECRUITING

Oregon Eye Consultants, Cascade Medical Research, Eugene

04101

RECRUITING

The Maine Eye Center, Portland

29926-2277

NOT_YET_RECRUITING

Hilton Head Retina Institute, Hilton Head

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Inflammasome Therapeutics

UNKNOWN

lead

University of Kentucky

OTHER